Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small cysteine and glycine repeat-containing protein 9 (SCYGR9) is likely a member of the keratin-associated protein (KAP) family, which are structural proteins that associate with keratin intermediate filaments in hair and wool through disulfide bonds, conferring mechanical properties such as strength and rigidity. The “KRTAP28p1” designation and several aliases indicate that this gene is a pseudogene, meaning it probably does not encode a functional protein in humans. While other KAPs are involved in hair structure and potentially cytoskeletal functions, there is no evidence that SCYGR9 is therapeutically actionable, involved in disease, or interacts with drugs. The nomenclature is inconsistent and may reflect either misannotation or overlap with other keratin-associated pseudogenes. Key points of caution: - “SCYGR9” and its aliases reference a keratin-associated pseudogene, making it highly unlikely to be a therapeutic target. - The lack of standardized nomenclature and functional evidence raises the possibility of misidentification or incomplete annotation. If you are searching for an actionable therapeutic target or biomarker, SCYGR9 does not currently qualify based on any available evidence. For structured data applications, mark it as incorrect for target curation purposes.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small cysteine and glycine repeat-containing protein 9 (SCYGR9).